2-acetylaminofluorene has been researched along with Bone Cancer in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcomas were found in 16 of 24,192 (0." | 1.26 | Osteosarcomas in BALB/c female mice. ( Frith, CH; Highman, B; Johnson, BP, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frith, CH | 1 |
| Johnson, BP | 1 |
| Highman, B | 1 |
1 other study available for 2-acetylaminofluorene and Bone Cancer
| Article | Year |
|---|---|
Osteosarcomas in BALB/c female mice.
Topics: 2-Acetylaminofluorene; Animals; Bone Neoplasms; Female; Lung Neoplasms; Mice; Mice, Inbred BALB C; O | 1982 |